ZNTL Zentalis Pharmaceuticals, Inc.

8d ago, source: Seeking Alpha

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products ...

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress

11d ago, source: Business Insider

Anticipated Upcoming Milestones First Quarter 2024 Financial Results About Azenosertib Zentalis ® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company discovering and developing ...

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock

10d ago, source:

View our latest analysis for Zentalis Pharmaceuticals . Zentalis Pharmaceuticals Insider Transactions Over The Last Year. The ...

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17d ago, source: Business Insider

NEW YORK and SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically ...

What is happening with Zentalis Pharmaceuticals Inc (ZNTL) Stock?

5d ago, source: bovnews

Currently, 10.10 percent of Zentalis Pharmaceuticals Inc shares are owned by insiders, and 108.51 percent are held by financial institutions. HAUSMAN DIANA, the Chief Medical Officer at Zentalis ...

Zentalis Pharmaceuticals Inc Ordinary Shares ZNTL

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress

11d ago, source: Stockhouse

CloseCurlyDoubleQuote; Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting ...

Zentalis Pharmaceuticals Inc.

19d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Zentalis Pharmaceuticals Inc Ordinary Shares

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17d ago, source: Stockhouse

NEW YORK and SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically ...

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress

11d ago, source: WWLP-22News

Zentalis ® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological ...